ACR Convergence 2020, the world’s premier virtual rheumatology experience, is happening online, November 5–9. We’ve reimagined the ACR’s annual meeting without losing the elements you care about most: stellar rheumatology education and outstanding networking opportunities. This fully virtual meeting is where rheumatology can collaborate, celebrate, innovate, and learn!

Your presence and participation are what make the meeting an enriching and valuable experience. We hope you will engage with us each step of the way, so that together we build an even stronger sense of community.

 

Annual Meeting registration

Registration

See the virtual pass options designed to offer flexibility and ultimate value.

Annual Meeting education

Program

Browse the online program and check out the all-new flexible meeting schedule.

Annual Meeting Abstracts

Abstracts

Late-breaking abstract submission is closed. View accepted abstracts.

 about=

About the Meeting

Read Frequently Asked Questions (FAQs) for more information about the virtual meeting.

Annual Meeting exhibitors

Exhibitors

Learn more about exhibits at ACR Convergence 2020.


ACR19 Resources

#ACR19 Resources

Take advantage of educational resources from the #ACR19 meeting.


 

Featured #ACR20 Sessions


The Great Debate: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA

Vibeke Strand, MD Michael Weinblatt, MD

Track: Rheumatoid Arthritis
November 6, 10:00–11:00 AM ET
Speakers: Vibeke Strand, MD, and Michael Weinblatt, MD
The 2015 ACR Guideline for the Treatment of RA specifies that TNF inhibitors should be used before JAK inhibitors for the treatment of RA when a patient fails to have an adequate response to conventional DMARDs. Since that time, emerging data indicates that jakinibs may be even more effective than TNF inhibitors. During this session, Drs. Strand and Weinblatt will revisit this recommendation and debate the pros and cons.
The Great Debate: Janus Kinase Inhibitors Should/Should Not Be Used Before Biologics After Methotrexate Failure in RA

 

Rheumatology Research Foundation Memorial Lectureship to Honor Shaun Ruddy, MD: Can We Predict & Prevent Pregnancy Complications in Patients with Lupus & APS?

Jane Salmon, MD

Track: Antiphospholipid syndrome
November 9, 3:00–4:00 PM ET
Speaker: Jane Salmon, MD
Pregnancy complications are common in lupus and antiphospholipid syndrome (APS). During this session, Dr. Salmon will review the predictors and mechanisms of pregnancy complications, as well as potential interventions for preventing pregnancy complications associated with lupus and APS.
Rheumatology Research Foundation Memorial Lectureship to Honor Shaun Ruddy, MD: Can We Predict & Prevent Pregnancy Complications in Patients with Lupus & APS?

ACR Convergence Twitter Ambassadors

The ACR has recruited rheumatology social media influencers to help build awareness of the all-virtual annual meeting while increasing engagement among members of the global rheumatology community. Be sure to follow these Twitter power users as they spread the word about this year’s meeting, including sessions and speakers of interest, networking opportunities, and the overall virtual meeting experience. Conference attendees will also have the opportunity to interact with the ambassadors in the Community Hubs throughout the meeting. Follow the ambassadors at their Twitter handles below, and don’t forget to use #ACR20 on social media.

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us